title: Immunoreactivity of p53, PSA and bcl-2 in amniotic fluid smears from the second trimester of pregnancy.
authors.forename: Pauline
authors.initials: P
authors.lastname: Athanassiadou
authors.forename: Maria
authors.initials: M
authors.lastname: Gonidi
authors.forename: Anna
authors.initials: A
authors.lastname: Liossi
authors.forename: Lydia
authors.initials: L
authors.lastname: Nakopoulou
authors.forename: Efthalia
authors.initials: E
authors.lastname: Petrakakou
authors.forename: Vassiliki
authors.initials: V
authors.lastname: Sakellariou
authors.forename: Aris
authors.initials: A
authors.lastname: Antsaklis
mesh_terms: D000328:Adult; D000653:Amniotic Fluid / Q000276:immunology / Q000378:metabolism*; D002869:Chromosome Aberrations / Q000196:embryology; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D011247:Pregnancy; D011262:Pregnancy Trimester, Second / Q000235:genetics / Q000276:immunology / Q000378:metabolism*; D011296:Prenatal Diagnosis; D017430:Prostate-Specific Antigen / Q000032:analysis* / Q000276:immunology; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000032:analysis* / Q000276:immunology; D016159:Tumor Suppressor Protein p53 / Q000032:analysis* / Q000276:immunology
chemical_list: D019253:Proto-Oncogene Proteins c-bcl-2; D016159:Tumor Suppressor Protein p53; D017430:Prostate-Specific Antigen